Fundz

ZERO Prostate Cancer Names Brian Bragg as Chief Mission Officer

PRIVATEApr 23, 2024

Position

Chief Mission Officer

Company

ZERO Prostate Cancer

Brian Bragg
brian@zerocancer.org
AlexandriaBiotechnologyHealth CareMedicalNon Profit

Description

ZERO Prostate Cancer is pleased to announce the appointment of Brian Bragg as its first-ever Chief Mission Officer. Brian Bragg, a distinguished expert in the healthcare and community health space, will lead the organization's bold mission-first strategy to reduce late-stage diagnoses, improve patient quality and quantity of life, and decrease mortality. He will also spearhead continued efforts to center health equity solutions into all of ZERO Prostate Cancer's education, support, and advocacy work

Other recent leadership changes in Medical and Non Profit

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ZERO Prostate Cancer, and when

A new leader at ZERO Prostate Cancer brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ZERO Prostate Cancer raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ZERO Prostate Cancer, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ZERO Prostate Cancer. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ZERO Prostate Cancer

Location

Alexandria, Virginia, United States

About

ZERO Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of our community. From early detection to survivorship, ZERO is the premier resource for prostate cancer patients and their families to access comprehensive support, make meaningful connections, and take action to save lives. Our dedicated national and chapter staff is joined by a growing team of passionate volunteer champions to increase advocacy, awareness, and community engagement to ZERO out prostate cancer. ZERO is recognized with four out of four stars by Charity Navigator and accredited by the Better Business Bureau. ZERO spends more on programs than any other prostate cancer charity, dedicating 85 cents of every dollar to support, education, and research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ZERO Prostate Cancer changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Brian
Likely contact at this company
••••••••@••••••••

See Brian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ZERO Prostate Cancer's next move

Learn about Strategic plan

ZERO Prostate Cancer changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.